Inactive Instrument

Press Releases Avanir Pharmaceuticals Inc

Equities

US05348P4019

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2014	Otsuka : Japan's Otsuka to buy Avanir for $3.5 billion ahead of patent cliff	RE
2014	NASDAQ OMX : names 14 stocks to test lower fee and rebate programme	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avanir Pharmaceuticals : Announces Appointment of Rohan Palekar as President and Chief Executive Officer	16-01-20	PR
Avanir Pharmaceuticals : Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer’s Disease	15-12-10	PU
Avanir Pharmaceuticals : Announces JAMA Publication of Phase II Study Results Showing AVP-923 Significantly Reduced Agitation in Patients with Alzheimer's Disease	15-09-22	PU
Avanir Pharmaceuticals : Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026	15-08-11	PU
Avanir Pharmaceuticals : Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II Study at Alzheimer's Association International Conference	15-07-23	PU
Avanir Pharmaceuticals : C O R R E C T I O N -- Avanir Pharmaceuticals, Inc./	15-06-30	PU
Avanir Pharmaceuticals : Announces Publication of Positive Phase IIIb Results from AVP-825 Head-to-Head COMPASS Study in the Journal "Headache"	15-06-17	PU
Avanir Pharmaceuticals : Announces Presentation of Survey Evaluating the Prevalence of Pseudobulbar Affect (PBA) Symptoms in Retired Professional Football Players at the 12th Annual North American Brain Injury Society Conference	15-05-05	PU
Avanir Pharmaceuticals : Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition	15-05-01	PU
Avanir Pharmaceuticals : Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise at the American Academy of Neurology (AAN) 2015 Annual Meeting	15-04-15	PU
Avanir Pharmaceuticals : Football Hall-of-Famer Barry Sanders Tackles Pseudobulbar Affect; A Little-known But Widespread Condition Caused by Brain Injury	15-01-21	PU
Avanir Pharmaceuticals : Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)	14-12-09	PR
Avanir Pharmaceuticals : Cancels Previously Scheduled Earnings Call	14-12-05	PR
Avanir Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	14-12-04	PR
Avanir Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Avanir Pharmaceuticals, Inc.	14-12-03	PR
Avanir Pharmaceuticals : To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion	14-12-02	PR
Avanir Pharmaceuticals : Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA	14-11-26	PR
Avanir Pharmaceuticals : to Participate in Two Conferences in December	14-11-24	PU
Avanir Pharmaceuticals : to Participate in Two Conferences in December	14-11-20	PR
Avanir Pharmaceuticals : Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine	14-11-07	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avanir Pharmaceuticals Inc

Equities

US05348P4019

Press Releases

Filters